Wall Street analysts forecast that Simulations Plus, Inc. (NASDAQ:SLP) will post $8.95 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for Simulations Plus' earnings, with the lowest sales estimate coming in at $8.89 million and the highest estimate coming in at $9.00 million. Simulations Plus reported sales of $8.03 million in the same quarter last year, which would suggest a positive year over year growth rate of 11.5%. The business is expected to report its next earnings report on Wednesday, November 11th.
According to Zacks, analysts expect that Simulations Plus will report full-year sales of $41.01 million for the current financial year, with estimates ranging from $40.93 million to $41.09 million. For the next financial year, analysts expect that the business will post sales of $50.22 million, with estimates ranging from $49.95 million to $50.49 million. Zacks' sales averages are an average based on a survey of analysts that follow Simulations Plus.
SLP has been the subject of several research reports. Raymond James initiated coverage on shares of Simulations Plus in a research report on Friday. They issued an "outperform" rating and a $95.00 price target for the company. Zacks Investment Research lowered shares of Simulations Plus from a "buy" rating to a "hold" rating in a research note on Wednesday, September 16th. BidaskClub lowered shares of Simulations Plus from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, October 7th. Oppenheimer assumed coverage on shares of Simulations Plus in a research note on Tuesday, September 8th. They set an "outperform" rating and a $79.00 price objective for the company. Finally, Craig Hallum boosted their price objective on shares of Simulations Plus from $56.00 to $75.00 and gave the stock a "buy" rating in a research note on Friday, July 10th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Simulations Plus presently has an average rating of "Buy" and an average target price of $80.00.
Shares of SLP opened at $72.28 on Friday. The company has a 50 day moving average price of $66.84 and a 200-day moving average price of $54.93. Simulations Plus has a fifty-two week low of $26.00 and a fifty-two week high of $77.89. The stock has a market capitalization of $1.29 billion, a PE ratio of 144.56, a PEG ratio of 6.76 and a beta of -0.19.
The business also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Monday, October 26th will be paid a dividend of $0.06 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.24 dividend on an annualized basis and a yield of 0.33%. Simulations Plus's payout ratio is 50.00%.
In other Simulations Plus news, Director Walter S. Woltosz sold 24,000 shares of the company's stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $66.13, for a total transaction of $1,587,120.00. Following the transaction, the director now owns 4,779,153 shares in the company, valued at approximately $316,045,387.89. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 28.96% of the company's stock.
Institutional investors have recently modified their holdings of the business. Victory Capital Management Inc. increased its stake in shares of Simulations Plus by 5.0% in the first quarter. Victory Capital Management Inc. now owns 15,031 shares of the technology company's stock worth $525,000 after acquiring an additional 713 shares during the period. BNP Paribas Arbitrage SA increased its stake in shares of Simulations Plus by 111.9% in the first quarter. BNP Paribas Arbitrage SA now owns 3,675 shares of the technology company's stock worth $128,000 after acquiring an additional 1,941 shares during the period. Nuveen Asset Management LLC increased its stake in shares of Simulations Plus by 21.2% in the first quarter. Nuveen Asset Management LLC now owns 52,469 shares of the technology company's stock worth $1,832,000 after acquiring an additional 9,188 shares during the period. Geode Capital Management LLC increased its stake in shares of Simulations Plus by 4.9% in the first quarter. Geode Capital Management LLC now owns 181,169 shares of the technology company's stock worth $6,326,000 after acquiring an additional 8,463 shares during the period. Finally, Wells Fargo & Company MN increased its stake in shares of Simulations Plus by 72.3% in the first quarter. Wells Fargo & Company MN now owns 80,446 shares of the technology company's stock worth $2,809,000 after acquiring an additional 33,762 shares during the period. Institutional investors and hedge funds own 59.61% of the company's stock.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Featured Story: What’s a Black Swan?
Get a free copy of the Zacks research report on Simulations Plus (SLP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
20 Stocks to Sell Now
Most people know that brokerage rankings are overstated because of pressure from publicly-traded companies. No investor relations person wants to see "hold" and "sell" ratings issued for their stock. In reality, a "buy" rating really means "hold." "Hold" ratings really mean "sell" and "sell" ratings mean get out while you still can.
If Wall Street's top analysts are consistently giving "hold" and "sell" ratings to a stock, you know there's a serious problem. We've compiled a list of the companies that Wall Street's top equities research analysts are consistently giving "hold" and "sell" ratings too. If you own one of these stocks, consider getting out while there's still time.
This slide show lists the 20 companies that have the lowest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.
View the "20 Stocks to Sell Now".